Post-prostatectomy radiation therapy for locally recurrent prostate cancer.

Related Articles

Post-prostatectomy radiation therapy for locally recurrent prostate cancer.

Expert Rev Anticancer Ther. 2017 Nov;17(11):1003-1012

Authors: Isharwal S, Stephenson AJ

Abstract
INTRODUCTION: Approximately 15-30% of men with localized prostate cancer will experience biochemical recurrence (BCR) after radical prostatectomy. Postoperative radiation therapy is used in men with adverse pathological features to reduce the risk of BCR or with curative intent in men with known BCR. In this study, we review the evidence for the adjuvant and salvage radiation therapy after radical prostatectomy. Areas covered: A literature review of the Medline and Embase databases was performed. The search strategy included the following terms: prostate cancer, adjuvant radiotherapy, salvage radiotherapy, radical prostatectomy, biochemical recurrence, and prostate cancer recurrence. Prospective randomized trials for the adjuvant radiotherapy and observational studies supporting salvage radiotherapy were included for discussion. Expert commentary: As postoperative radiotherapy is associated with non-trivial risks of acute and long-term toxicity and given the absence of compelling data supporting adjuvant over early salvage radiotherapy, the authors advocate, with rare exceptions, close observation and timely (early) salvage radiotherapy for patients with BCR and long life expectancy. Adjuvant radiotherapy may be considered in patients at high-risk for recurrence. Observation is appropriate in patients with limited life expectancy and/or absence of adverse features.

PMID: 28922958 [PubMed - indexed for MEDLINE]

from #PM All via ola Kala on Inoreader http://ift.tt/2zkA8cu